VaramirStart free · no cardSign in
SDGR as of Nov 1 · 02:30 ET
SDGRNasdaqPharmaceutical Preparations

Schrodinger, Inc. · Brief

Next report

3 days

Nov 4 · after closeest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
1 of 8≥ implied
avg implied
±14.4%
avg realized
±5.1%
Nov 12 '24±13.2%▲+13.87%×1.05
Feb 26 '25±15.7%▲+2.53%×0.16
May 7 '25±13.4%▲+0.67%×0.05
Aug 6 '25±10.8%▲+0.10%×0.01
Q3 FY25±16.8%▼−5.67%×0.34
Q1 FY26±20.5%▲+8.14%×0.40
May 5 '26±12.7%▲+0.85%×0.07
Q2 FY26±12.1%▲+8.60%×0.71
quarterimplied−25%0+25%realized×
Q2 FY26±12.1%▲+8.60%×0.71
May '26±12.7%▲+0.85%×0.07
Q1 FY26±20.5%▲+8.14%×0.40
Q3 FY25±16.8%▼−5.67%×0.34
Aug '25±10.8%▲+0.10%×0.01
May '25±13.4%▲+0.67%×0.05
2 older reports
Feb '25±15.7%▲+2.53%×0.16
Nov '24±13.2%▲+13.87%×1.05
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 4 report · est.

Bull1

12disclosed supplier and customer ties in SEC filingsSEC filings

Bear1

7 of 8recent reports where the move came in under the options implied rangeEarnings history
AI captions · Sep 16 '26once per report · top 2 per case

Linked exposure

SDGR report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 21impliedImplied move: ±18.9% into Nov 4 earnings (Oct 21 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.